Naftopidil is a selective alpha-1 adrenergic antagonist primarily indicated for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. This category provides a comprehensive… Read more







Naftopidil is a selective alpha-1 adrenergic antagonist primarily indicated for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. This category provides a comprehensive selection of high-quality reference standards essential for analytical testing, impurity profiling, and rigorous quality control within pharmaceutical laboratories. By utilizing these materials, researchers and analysts can accurately identify and quantify process-related impurities and degradation products that may impact drug stability and efficacy. Additionally, the availability of stable isotope labelled compounds, such as deuterium-labelled variants, facilitates precise quantification through mass spectrometry-based assays. Incorporating these verified standards into method development and validation processes ensures compliance with regulatory guidelines and supports the accurate assessment of API purity and consistency throughout the pharmaceutical lifecycle.